Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 2007;92:257-260; doi:10.1136/adc.2006.095513
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

REVIEW

Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how?

Roderick Skinner1, W Hamish B Wallace2, Gillian Levitt3

1 Department of Paediatric and Adolescent Oncology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
2 Department of Paediatric Haematology and Oncology, Royal Hospital for Sick Children, Lothian University Hospitals NHS Trust, Edinburgh, UK
3 Department of Oncology and Haematology, Great Ormond Street Hospital for Sick Children NHS Trust, London, UK

Correspondence to:
Correspondence to:
Dr R Skinner
Department of Paediatric and Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Paediatric Oncology Day Unit, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK; roderick.skinner{at}ncl.ac.uk

ABSTRACT

About 1 in 715 young adults is a survivor of childhood malignancy, but these individuals are at increased risk of considerable treatment-related morbidity or even mortality. A recent study suggests that at least 60% have one or more chronic health problems, whilst about 20% have three or more. The principle goal of long-term follow-up (LTFU) of survivors is to decrease the severity of late treatment complications by performing appropriate surveillance to detect incipient toxicity, and by facilitating timely diagnosis and management of emerging or established late adverse effects. The content of LTFU is dictated by the type and amount of treatment for the malignancy, and has been defined in recent clinical guidelines. Moreover, LTFU allows provision of survivor education, psychosocial support and health promotion advice. However, considerable variation exists in how LTFU is performed, with several alternative models involving a range of professionals in a variety of locations, depending on numerous clinical and organisational factors. There is increasing utilisation of multidisciplinary teams, and recognition of the importance of effective transition strategies whereby care is transferred to more age-appropriate providers, usually after a period of joint care in adolescence. It is of paramount importance to ascertain and meet the needs of survivors themselves.

Abbreviations: LTFU, long-term follow-up; HSCT, haemopoietic stem cell transplantation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

A brief digest of the March issue
Arch. Dis. Child. 2007 92: e3. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Eshelman-Kent, D., Gilger, E., Gallagher, M. (2009). Transitioning Survivors of Central Nervous System Tumors: Challenges for Patients, Families, and Health Care Providers. Journal of Pediatric Oncology Nursing 26: 280-294 [Abstract]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs